{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,27]],"date-time":"2026-09-27T23:53:17Z","timestamp":1790553197080,"version":"4.1.0"},"reference-count":35,"publisher":"Springer Science and Business Media LLC","issue":"3","license":[{"start":{"date-parts":[[2018,3,20]],"date-time":"2018-03-20T00:00:00Z","timestamp":1521504000000},"content-version":"tdm","delay-in-days":0,"URL":"http:\/\/www.springer.com\/tdm"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Am J Clin Dermatol"],"published-print":{"date-parts":[[2018,6]]},"DOI":"10.1007\/s40257-018-0349-6","type":"journal-article","created":{"date-parts":[[2018,3,20]],"date-time":"2018-03-20T03:39:35Z","timestamp":1521517175000},"page":"449-455","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":30,"title":["The Use of Hormonal Antiandrogen Therapy in Female Patients with Acne: A 10-Year Retrospective Study"],"prefix":"10.1007","volume":"19","author":[{"given":"Joyce H.","family":"Park","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Amanda","family":"Bienenfeld","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Seth J.","family":"Orlow","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Arielle R.","family":"Nagler","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2018,3,20]]},"reference":[{"issue":"1","key":"349_CR1","doi-asserted-by":"publisher","first-page":"56","DOI":"10.1016\/j.jaad.2007.06.045","volume":"58","author":"CN Collier","year":"2008","unstructured":"Collier CN, Harper JC, Cafardi JA, Cantrell WC, Wang W, Foster KW, et al. The prevalence of acne in adults 20\u00a0years and older. J Am Acad Dermatol. 2008;58(1):56\u20139.","journal-title":"J Am Acad Dermatol"},{"issue":"Suppl 1","key":"349_CR2","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1111\/bjd.13933","volume":"172","author":"B Dreno","year":"2015","unstructured":"Dreno B. The changing faces of acne. Br J Dermatol. 2015;172(Suppl 1):1\u20132.","journal-title":"Br J Dermatol"},{"issue":"6","key":"349_CR3","doi-asserted-by":"publisher","first-page":"541","DOI":"10.1046\/j.1468-3083.2001.00357.x","volume":"15","author":"F Poli","year":"2001","unstructured":"Poli F, Dreno B, Verschoore M. An epidemiological study of acne in female adults: results of a survey conducted in France. J Eur Acad Dermatol Venereol JEADV. 2001;15(6):541\u20135.","journal-title":"J Eur Acad Dermatol Venereol JEADV"},{"issue":"2","key":"349_CR4","doi-asserted-by":"publisher","first-page":"168","DOI":"10.1016\/j.clindermatol.2016.10.009","volume":"35","author":"B Barros","year":"2017","unstructured":"Barros B, Thiboutot D. Hormonal therapies for acne. Clin Dermatol. 2017;35(2):168\u201372.","journal-title":"Clin Dermatol."},{"issue":"4","key":"349_CR5","doi-asserted-by":"publisher","first-page":"363","DOI":"10.1210\/edrv.21.4.0404","volume":"21","author":"D Deplewski","year":"2000","unstructured":"Deplewski D, Rosenfield RL. Role of hormones in pilosebaceous unit development. Endocr Rev. 2000;21(4):363\u201392.","journal-title":"Endocr Rev"},{"issue":"6","key":"349_CR6","doi-asserted-by":"publisher","first-page":"479","DOI":"10.1007\/s40257-014-0099-z","volume":"15","author":"S Das","year":"2014","unstructured":"Das S, Reynolds RV. Recent advances in acne pathogenesis: implications for therapy. Am J Clin Dermatol. 2014;15(6):479\u201388.","journal-title":"Am J Clin Dermatol"},{"issue":"9","key":"349_CR7","doi-asserted-by":"publisher","first-page":"1063","DOI":"10.1111\/jdv.12061","volume":"27","author":"B Dreno","year":"2013","unstructured":"Dreno B, Layton A, Zouboulis CC, Lopez-Estebaranz JL, Zalewska-Janowska A, Bagatin E, et al. Adult female acne: a new paradigm. J Eur Acad Dermatol Venereol JEADV. 2013;27(9):1063\u201370.","journal-title":"J Eur Acad Dermatol Venereol JEADV"},{"issue":"3","key":"349_CR8","doi-asserted-by":"publisher","first-page":"144","DOI":"10.1053\/sder.2001.28208","volume":"20","author":"D Thiboutot","year":"2001","unstructured":"Thiboutot D. Hormones and acne: pathophysiology, clinical evaluation, and therapies. Semin Cutan Med Surg. 2001;20(3):144\u201353.","journal-title":"Semin Cutan Med Surg"},{"issue":"5","key":"349_CR9","doi-asserted-by":"publisher","first-page":"419","DOI":"10.1016\/j.clindermatol.2004.03.010","volume":"22","author":"D Thiboutot","year":"2004","unstructured":"Thiboutot D. Acne: hormonal concepts and therapy. Clin Dermatol. 2004;22(5):419\u201328.","journal-title":"Clin Dermatol."},{"issue":"Suppl 3","key":"349_CR10","doi-asserted-by":"publisher","first-page":"57","DOI":"10.1046\/j.0926-9959.2001.00014.x","volume":"15","author":"DM Thiboutot","year":"2001","unstructured":"Thiboutot DM. Endocrinological evaluation and hormonal therapy for women with difficult acne. J Eur Acad Dermatol Venereol JEADV. 2001;15(Suppl 3):57\u201361.","journal-title":"J Eur Acad Dermatol Venereol JEADV."},{"issue":"5","key":"349_CR11","doi-asserted-by":"publisher","first-page":"945e33","DOI":"10.1016\/j.jaad.2015.12.037","volume":"74","author":"AL Zaenglein","year":"2016","unstructured":"Zaenglein AL, Pathy AL, Schlosser BJ, Alikhan A, Baldwin HE, Berson DS, et al. Guidelines of care for the management of acne vulgaris. J Am Acad Dermatol. 2016;74(5):945e33\u2013973e33.","journal-title":"J Am Acad Dermatol."},{"key":"349_CR12","doi-asserted-by":"crossref","unstructured":"Arowojolu AO, Gallo MF, Lopez LM, Grimes DA. Combined oral contraceptive pills for treatment of acne. Cochrane Database Syst Rev. 2012;(6):CD004425.","DOI":"10.1002\/14651858.CD004425.pub5"},{"issue":"2","key":"349_CR13","first-page":"83","volume":"90","author":"EA Arrington","year":"2012","unstructured":"Arrington EA, Patel NS, Gerancher K, Feldman SR. Combined oral contraceptives for the treatment of acne: a practical guide. Cutis. 2012;90(2):83\u201390.","journal-title":"Cutis"},{"issue":"Suppl 1","key":"349_CR14","doi-asserted-by":"publisher","first-page":"37","DOI":"10.1111\/bjd.13681","volume":"172","author":"V Bettoli","year":"2015","unstructured":"Bettoli V, Zauli S, Virgili A. Is hormonal treatment still an option in acne today? Br J Dermatol. 2015;172(Suppl 1):37\u201346.","journal-title":"Br J Dermatol"},{"issue":"7","key":"349_CR15","doi-asserted-by":"publisher","first-page":"1042","DOI":"10.1139\/o79-131","volume":"57","author":"A Boisselle","year":"1979","unstructured":"Boisselle A, Dionne FT, Tremblay RR. Interaction of spironolactone with rat skin androgen receptor. Can J Biochem. 1979;57(7):1042\u20136.","journal-title":"Can J Biochem"},{"issue":"5","key":"349_CR16","doi-asserted-by":"publisher","first-page":"452","DOI":"10.1111\/j.1529-8019.2009.01261.x","volume":"22","author":"JC Harper","year":"2009","unstructured":"Harper JC. Should dermatologists prescribe hormonal contraceptives for acne? Dermatol Ther. 2009;22(5):452\u20137.","journal-title":"Dermatol Ther."},{"key":"349_CR17","first-page":"213","volume":"1","author":"JK Tan","year":"2010","unstructured":"Tan JK, Ediriweera C. Efficacy and safety of combined ethinyl estradiol\/drospirenone oral contraceptives in the treatment of acne. Int J Womens Health. 2010;1:213\u201321.","journal-title":"Int J Womens Health."},{"issue":"3","key":"349_CR18","doi-asserted-by":"publisher","first-page":"450","DOI":"10.1016\/j.jaad.2014.03.051","volume":"71","author":"EB Koo","year":"2014","unstructured":"Koo EB, Petersen TD, Kimball AB. Meta-analysis comparing efficacy of antibiotics versus oral contraceptives in acne vulgaris. J Am Acad Dermatol. 2014;71(3):450\u20139.","journal-title":"J Am Acad Dermatol"},{"issue":"2","key":"349_CR19","doi-asserted-by":"publisher","first-page":"209","DOI":"10.1111\/j.1365-2133.1984.tb04045.x","volume":"111","author":"A Goodfellow","year":"1984","unstructured":"Goodfellow A, Alaghband-Zadeh J, Carter G, Cream JJ, Holland S, Scully J, et al. Oral spironolactone improves acne vulgaris and reduces sebum excretion. Br J Dermatol. 1984;111(2):209\u201314.","journal-title":"Br J Dermatol"},{"issue":"2","key":"349_CR20","doi-asserted-by":"publisher","first-page":"227","DOI":"10.1111\/j.1365-2133.1986.tb05722.x","volume":"115","author":"MF Muhlemann","year":"1986","unstructured":"Muhlemann MF, Carter GD, Cream JJ, Wise P. Oral spironolactone: an effective treatment for acne vulgaris in women. Br J Dermatol. 1986;115(2):227\u201332.","journal-title":"Br J Dermatol"},{"issue":"2","key":"349_CR21","first-page":"CD000194","volume":"15","author":"J Brown","year":"2009","unstructured":"Brown J, Farquhar C, Lee O, Toomath R, Jepson RG. Spironolactone versus placebo or in combination with steroids for hirsutism and\/or acne. Cochrane Database Syst Rev. 2009;15(2):CD000194.","journal-title":"Cochrane Database Syst Rev."},{"key":"349_CR22","doi-asserted-by":"publisher","first-page":"169","DOI":"10.1007\/s40257-016-0245-x","volume":"2","author":"AM Layton","year":"2017","unstructured":"Layton AM, Eady EA, Whitehouse H, Del Rosso JQ, Fedorowicz Z, van Zuuren EJ. Oral spironolactone for acne vulgaris in adult females: a hybrid systematic review. Am J Clin Dermatol. 2017;2:169\u201391.","journal-title":"Am J Clin Dermatol"},{"issue":"9","key":"349_CR23","doi-asserted-by":"publisher","first-page":"1480","DOI":"10.1111\/jdv.13675","volume":"30","author":"HP Gollnick","year":"2016","unstructured":"Gollnick HP, Bettoli V, Lambert J, Araviiskaia E, Binic I, Dessinioti C, et al. A consensus-based practical and daily guide for the treatment of acne patients. J Eur Acad Dermatol Venereol JEADV. 2016;30(9):1480\u201390.","journal-title":"J Eur Acad Dermatol Venereol JEADV."},{"issue":"8","key":"349_CR24","doi-asserted-by":"publisher","first-page":"1261","DOI":"10.1111\/jdv.13776","volume":"30","author":"A Nast","year":"2016","unstructured":"Nast A, Dreno B, Bettoli V, Bukvic Mokos Z, Degitz K, Dressler C, et al. European evidence-based (S3) guideline for the treatment of acne-update 2016-short version. J Eur Acad Dermatol Venereol JEADV. 2016;30(8):1261\u20138.","journal-title":"J Eur Acad Dermatol Venereol JEADV."},{"issue":"3","key":"349_CR25","doi-asserted-by":"publisher","first-page":"456e4","DOI":"10.1016\/j.jaad.2017.04.016","volume":"77","author":"JS Barbieri","year":"2017","unstructured":"Barbieri JS, James WD, Margolis DJ. Trends in prescribing behavior of systemic agents used in the treatment of acne among dermatologists and nondermatologists: a retrospective analysis, 2004\u20132013. J Am Acad Dermatol. 2017;77(3):456e4\u2013463e4.","journal-title":"J Am Acad Dermatol."},{"issue":"2S1","key":"349_CR26","first-page":"S1","volume":"78","author":"DM Thiboutot","year":"2017","unstructured":"Thiboutot DM, Dreno B, Abanmi A, Alexis AF, Araviiskaia E, Barona Cabal MI, et al. Practical management of acne for clinicians: an international consensus from the Global Alliance to Improve Outcomes in Acne. J Am Acad Dermatol. 2017;78(2S1):S1\u201323.e1.","journal-title":"J Am Acad Dermatol."},{"issue":"4","key":"349_CR27","doi-asserted-by":"publisher","first-page":"249","DOI":"10.1001\/jamadermatol.2016.5096","volume":"153","author":"CP Neuhaus","year":"2017","unstructured":"Neuhaus CP, Nagler AR, Orlow SJ. Teens, acne, and oral contraceptive pills: the need for greater clarity on when teens can consent. JAMA Dermatol. 2017;153(4):249\u201350.","journal-title":"JAMA Dermatol."},{"issue":"3","key":"349_CR28","doi-asserted-by":"publisher","first-page":"188","DOI":"10.1016\/j.sder.2008.06.002","volume":"27","author":"R George","year":"2008","unstructured":"George R, Clarke S, Thiboutot D. Hormonal therapy for acne. Semin Cutan Med Surg. 2008;27(3):188\u201396.","journal-title":"Semin Cutan Med Surg"},{"issue":"1 Suppl","key":"349_CR29","doi-asserted-by":"publisher","first-page":"S1","DOI":"10.1067\/mjd.2003.618","volume":"49","author":"H Gollnick","year":"2003","unstructured":"Gollnick H, Cunliffe W, Berson D, Dreno B, Finlay A, Leyden JJ, et al. Management of acne: a report from a global alliance to improve outcomes in acne. J Am Acad Dermatol. 2003;49(1 Suppl):S1\u201337.","journal-title":"J Am Acad Dermatol"},{"issue":"Suppl 1","key":"349_CR30","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1111\/j.1468-3083.2011.04374.x","volume":"26","author":"A Nast","year":"2012","unstructured":"Nast A, Dreno B, Bettoli V, Degitz K, Erdmann R, Finlay AY, et al. European evidence-based (S3) guidelines for the treatment of acne. J Eur Acad Dermatol Venereol JEADV. 2012;26(Suppl 1):1\u201329.","journal-title":"J Eur Acad Dermatol Venereol JEADV."},{"issue":"6","key":"349_CR31","first-page":"391","volume":"14","author":"B Dreno","year":"2004","unstructured":"Dreno B, Bettoli V, Ochsendorf F, Layton A, Mobacken H, Degreef H, et al. European recommendations on the use of oral antibiotics for acne. Eur J Dermatol. 2004;14(6):391\u20139.","journal-title":"Eur J Dermatol."},{"issue":"3","key":"349_CR32","doi-asserted-by":"crossref","first-page":"330","DOI":"10.1684\/ejd.2014.2309","volume":"24","author":"B Dreno","year":"2014","unstructured":"Dreno B, Thiboutot D, Gollnick H, Bettoli V, Kang S, Leyden JJ, et al. Antibiotic stewardship in dermatology: limiting antibiotic use in acne. Eur J Dermatol. 2014;24(3):330\u20134.","journal-title":"Eur J Dermatol."},{"issue":"5 Suppl","key":"349_CR33","doi-asserted-by":"publisher","first-page":"S1","DOI":"10.1016\/j.jaad.2009.01.019","volume":"60","author":"D Thiboutot","year":"2009","unstructured":"Thiboutot D, Gollnick H, Bettoli V, Dreno B, Kang S, Leyden JJ, et al. New insights into the management of acne: an update from the global alliance to improve outcomes in acne group. J Am Acad Dermatol. 2009;60(5 Suppl):S1\u201350.","journal-title":"J Am Acad Dermatol"},{"issue":"1","key":"349_CR34","doi-asserted-by":"publisher","first-page":"70","DOI":"10.1016\/j.jaad.2014.02.031","volume":"71","author":"YH Lee","year":"2014","unstructured":"Lee YH, Liu G, Thiboutot DM, Leslie DL, Kirby JS. A retrospective analysis of the duration of oral antibiotic therapy for the treatment of acne among adolescents: investigating practice gaps and potential cost-savings. J Am Acad Dermatol. 2014;71(1):70\u20136.","journal-title":"J Am Acad Dermatol"},{"issue":"2","key":"349_CR35","doi-asserted-by":"publisher","first-page":"273","DOI":"10.1016\/j.jaad.2015.09.046","volume":"74","author":"AR Nagler","year":"2016","unstructured":"Nagler AR, Milam EC, Orlow SJ. The use of oral antibiotics before isotretinoin therapy in patients with acne. J Am Acad Dermatol. 2016;74(2):273\u20139.","journal-title":"J Am Acad Dermatol"}],"container-title":["American Journal of Clinical Dermatology"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/link.springer.com\/article\/10.1007\/s40257-018-0349-6\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s40257-018-0349-6.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s40257-018-0349-6.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2020,10,29]],"date-time":"2020-10-29T17:21:57Z","timestamp":1603992117000},"score":1,"resource":{"primary":{"URL":"http:\/\/link.springer.com\/10.1007\/s40257-018-0349-6"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2018,3,20]]},"references-count":35,"journal-issue":{"issue":"3","published-print":{"date-parts":[[2018,6]]}},"alternative-id":["349"],"URL":"https:\/\/doi.org\/10.1007\/s40257-018-0349-6","relation":{},"ISSN":["1175-0561","1179-1888"],"issn-type":[{"value":"1175-0561","type":"print"},{"value":"1179-1888","type":"electronic"}],"subject":[],"published":{"date-parts":[[2018,3,20]]},"assertion":[{"value":"20 March 2018","order":1,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Compliance with Ethical Standards"}},{"value":"No funding was provided for conduct of the study and\/or preparation of the paper. No funding organization or sponsor was involved in any aspect of the following: design and conduct of the study; collection, management, analysis, and interpretation of the data; and preparation, review, or approval of the manuscript.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Funding"}},{"value":"In the past 12\u00a0months, Dr Seth Orlow has served as a consultant for Dermira, on the advising board for Unilever, and as a board member for Almirall. Dr Nagler, Dr Park, and Ms Bienenfeld have no conflicts of interest to declare.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Conflict of interest"}}]}}